Submitted far publicatian March 1, 1993 Cell ingrowth, hydroxyproline accumulation, and mRN A expression of collagen 1 were measured in two polytetraftuoroethylene grafts implanted subcutaneously at the time of colorectal cancer surgery to evaluate tbe inftuence of early postoperative cbemotherapy on buman wound healing.
Eleven patients treated with intraperitoneal 5-ftuorouracil and intravenous folinic acid Days 1-6 after operation were compared with 15 patients wbo underwent surgcry alone. At 1 wcek, cbcmotherapy-treated paticnts had accumulatcd less bydroxyproline (mean 0.35 :t 0.33 p.gfcm) comparcd with untreated patients (mean 0.73 :t 0.37 p.gfcm, P < 0.05). By 2 wecks, the hydroxyprolinc content bad increased sixfold in thc chemotherapy group (P < 0.01) and thrcefold in thc nonchcmothcrapy group (P < 0.01) and there was no difTcrencc bctwccn the groups. Ccll and connectivc tissuc ingrowth and total RNA content did not difTcr betwecn the groups at any point in time, but at 1 week thc mRN A cxprcssion of collagen 1 was higbcr in the chemothcrapy group (P < 0.05). These results indicate that collagen accumulation in human subjects is reduced during a short course of postoperative cbemotherapy and normalizes after the end of treatment.
(!;) 1994 Acodcmic Prcss. loco toneal administration appears to impair postoperative collagen synthesis [7] . Although numerous animal studies have shown that 5-FU inhibits wo1.Jnd healing, it is not known if there is an analogous effect in human subjects treated with clases commonly used in adjuvant therapy. Such knowledge would be valuable for the application of results from animal studies to humans and hence for assessing the risks connected with early postoperative chemotherapy.
This study was undertaken to analyze the efrects of early postoperative intraperitoneal 5-FU infusion on human wound healing through comparing treated patients with those submitted to surgery alone with respect to cell migration and collagen accumulation in a standardized subcutaneous wound.
PATIENTS ANO METHOOS

Patients
Surgical morbidity and tolerance to adjuvant intraperitoneal chemotherapy were studied in a randomized multicenter phase 1 trial involving patients not older than 75 years who were scheduled for a colorectal cancer resection with curative intent between February 1990 and April 1992. Fifty patients were randomized to receive intraperitoneal 5-FU and intravenous folinic acid, and 51 to receive placebo, in a double-blind manner. Folinic acid was given with the aim of improving the antitumor activity of 5-FU [8] . The active treatment consisted of 500 mg/m2/day 5-FU (Cyanamid Nordiska AB, Stockholm, Sweden) as an intraperitoneal infusion given over a 30-min period and 60 mg/m2/day folinic acid (Leucovorin, Cyanamid Nordiska AB) as an intravenous infusion lasting 5-10 min and commencing 1 hr after the start ofthe intraperitoneal infusion. The 5-FU was dissolved in 500 mI of 0.9% NaCI and the Leucovorin in 100 mI of 0.9% NaCI. Patients in the placebo arm received only the vehicle according to the same schedule. The treatment started on the day after surgery INTRODUCTION Adjuvant intraportal 5-fluorouracil (5-FU) infusion has been associated with an improved survival after curative surgery for colorectal cancer [1] . Intraperitoneal administration has been suggested as an alternative to intraportal infusion to expose algo peritoneal and local tumor remnants to the cytotoxic drug [2] . However, several experimental studies have shown that 5-FU reduces the strength of surgical wounds [3-+5] , most likely due to reduced collagen formation [5, 6] . Particularly, intraperiITo whom correspondence and reprint requests should be ad dressed.
The grafts were cut into 7 -cm lengths and sterilized in an autoclave. During anaesthesia for colorectal cancel surgery, the extensor part of the right upper arm was cleaned with chlorohexidine and wiped dry. A small stab wound was made with a surgical blade approximately halfway between the elbow and shoulder. A 2 X 50-mm crista biopsy needle (Cameco AB, Tiiby, Sweden) was inserted subcutaneously, with the tip emerging at a distance large enough to allow the graft to be placed in straight position. The tlachar was removed and a guide wire with the graft threaded on it was inserted through the needle, and while the graft was held with a forceps, first the guide wire and then the needle were withdrawn. Two 7 -cm grafts were placed parallel to each other approximately 3-cm aparto One centimeter of the graft protruded outside the ski n and was fixed with a suture. The grafts were covered with a sterile dressing. This method was originally described by Goodson and Hunt [9] . One graft was extracted after 1 wliek and the other after 2 weeks. After extraction, the grafts were divided in a standardized fashion; the innermost 8 mm was taken for histology, the next 20 mm for RNA extraction, and the next 30 mm for determination of hydroxyproline; the last part, the 1 cm outside the skin and a further 2 mm, was discarded. The pieces were immediately measured to the nearest millimeter, weighed, and thereafter frozen in liquid N2 and stored at -70°C until analysed.
TABLEl Patient Characteristics
Chemotherapy Nonchemotherapy (n = 11) (n = 15) and continued for 6 consecutive days with a break on Sundays. Twenty-two patients treated within the trial at our department were included in the present study. Also included in the study were four patients eligible preoperatively for the randomized trial, but in whom exclusion criteria were found at surgery (in two cases metastatic disease and in two suspected Dukes',A lesions), giving a total of 11 patients treated with chemotherapy postoperatively and 15 undergoing surgery alone (1'able 1).
The average (:tSD) preoperative weight loss was 2.9 :t 4.3 in the chemotherapy group and 2.5 :t 2.9 in the nonchemotherapy group. The corresponding values for body mass index (body weightflength2) and S-albumin were 24.8 :t 5.0 and 23.9 :t 3.7 and 39 :t 4.9 and 41 :t 3.4, respectively. There was no indication of a difference in immunocompetence between the groups as reflected by preoperative hematological values (data not shown). Neither did variables reflecting the surgical trauma (i.e., operating time, preoperative bleeding, and number of units of blood transfused) differ between the groups (data not presented). During the conduct of the analyses, the investigators had no knowledge about the randoro allocation of the patients in the trial but knew which patients were outside the trial. The studywas approved by the regional ethics committee and informed consent was obtained from all patients.
Hydroxyproline
As.s-ay
The hydroxyproline content was measured as described by Stegemann and Stalder [10] . Briefiy, the graft was cut into 2-mm pieces and hydrolyzed in 1 mI HCI 6 mole/liter at 110°C for 21 hr. The hydrolysate was evaporized to dryness and dissolved in 500 11.1 deionized water. Buffer was added to a volume of 2 mI. The sample was then incubated with 1 mI chloramine T at room temperature for 20 mino One milliliter of aldehyde/perchloric acid solution was then added, and the admixture was shaken thoroughly and immersed in a 60°C water bath for 15 mino After cooling, the absorbance was read in a spectrophotometer at 550 nm. To assess the variation in the hydroxyproline content along the graft, determinations based on two different parts of the 30-mm graft segment were performed in 35/52 measurements. There was a close correlation between the two determinations (r = 0.93, P < 0.0001) (Fig. 1) . The total amount of hydroxyproline per totallength of graft (i.e., the weighted mean) was used in the presentation of results. The compositions of the various solutions are detailed elsewhere [10] .
Technique Polytetratluoroethylene (PTFE) grafts, 1 mm in diameter and with a 90-}J.m pore size, were purchased from Gore, Swedish AB (Molndal, Sweden). The weightf length ratio was close to constant (0.46 ::!: 0.03 mgfmm).
RNA Analyses
Total RNA was extracted by the acid-guanidiniumphenol-chloroform method [11] and quantitated by spectrophotometry at 260 nm, and the results were expressed 5.0 tometry of autoradiographs from the hybridized dot blot filters, a pro a1(I)/oligo(dT) index was created for each sample and these figures were compared for relative values ofpro a1(I) mRNA levels. Absolute levels ofmRNA expression of collagen 1 were calculated only in the 14 patients evaluated with the oligo(dT) method, but relative changes were calculated for all patients. After fixation in 10% formaldehyde overnight, the grafts were dehydrated in ethanol and embedded in the plastic medium JB4 (Bio-Rad, Richmond, CA), and 2-to 3-ILm thick sections were cut 10ngitudinaUy. A hematoxylin-eosin-stained coded section was inspected for ceU and connective tissue ingrowth (Figs. 2 and 3) . A quantification of the degree of invasion of tissue into the pores was performed after identification of the fibroblast-containing organized granulation tissue and for each pore described as the location ofthe edge ofllthis compartment (arrowhead in Fig. 3 ). This was estimated to be O, 25, 50, 75, or 100% of the totallength of the pore. The mean of 40 randomly selected transversaUy sectioned pores was given for each patient and each time. as /lg/cm. Serial dilutions of formaldehyde-denatured RNA were dot blotted anta nylon membranes (Amersham, UK) with the aid of a vacuum chamber device (Bio-Rad, Richmond, CA), fixed on a bed of 0.05 mole/ liter NaOH, and washed briefty in standard saline phosphate EOTA (0.30 mole/liter NaCl, 20 mmole/liter, NaH;¿PO4' 2 mmole/liter EOTA, pH 7.4). The membranes were then subjected to hybridization with a 372-bp cONA probe corresponding to a conserved regían of the collagen al(I) chain (a gift from Dr. E. Vuorio, University of Turku, Finland). The probe was labeled with 32p by the random priming method (Amersham, UK). Autoradiographs were evaluated by laser densitometry. As an internal reference for the mRNA measurements, two different methods were used. Initially, the glyceraldehyde-3-phosphate dehydrogenase (GAPOH) method was employed in which the membranes were reprobed with a 700-bp cDNA probe corresponding to the GAPDH enzyme ofthe glycolysis, labeled exactly in the same way. This probe served as a positive control and as a reference for comparison ofthe different RNA samples in the densitometry assay, as it is considered to be a constitutively expressed gene producto In the later part ofthe study (n = 14), the oligo(dT) method was used in which mRNA was semiquantitated as described by Harley [12] . Briefty, RNA was dot blotted anta a nitrocellulose filter and subsequently hybridized with a 32p end-Iabeled 0Iigo(dT)18 probe which detects total mRNA by binding to its poly(A) tail. The oligo(dT) 18 was removed by stringent washing and the filter was finally exposed to the collagen pro al(I) cDNA probe. After laser densiStati,-;tical Method.'i Results are presented as means ::t standard deviation. Statistical comparisons between the groups were roade with the Mann-Whitney U test and temporal changes within the groups with the Wilcoxon signed rank test. All presented P values are two-tailed.
RESULTS
Postoperatiue Course
Anastomotic dehiscence was diagnosed in one patient in each group, one of whom required a second laparotomy. Furthermore, two patients treated with 5-FU experienced surgical complications; one had severe localized abdominal pain and rebound tenderness, which resolved spontaneously, a condition judged as chemical peritonitis [13] , and the other had a perineal infection after an abdominoperineal resection. A leukopenia was observed in one patient in the chemotherapy group (white blood cell count 1.1 X 109jliter on the third day of treatment). In all other patients the postoperative course was uneventful. Among the 11 patients treated with chemotherapy, 8 received the intended six treatments, whereas it was terminated on Days 2, 3, and 4 in the remaining three patients.
Graft Weights and Hydroxyproline
No signs of infection appeared around the grafts and removal was always easy. At 1 week, the graft weight was The difference ayer time was significant in both groups (P < 0.05). By 1 week, the hydroxyproline content in the chemotherapy group was lower than that in the nonchemotherapy group (P < 0.05). This was algo true when hydroxyproline accumulation was expressed as concentration (P < 0.05, Table 2 ). Compared with 1 week, a marked increment in hydroxyproline accumulation had occurred at 2 weeks in both groups (P < 0.01), when it was approximately equal in the two groups (Table 2) .
of collagen 1 was 0.70 :t 0.40 in the chemotherapy group (n = 7) and 0.28:t 0.19 in the nonchemotherapy group (n = 7) (P < 0.03). By 2 weeks the corresponding figures were 0.88 :t 0.64 and 0.38 ::!: 0.27, respectively (P = 0.10). The relative change in mRNA expression oí collagen 1 was 223 ::!: 213% in the chemotherapy group and 191 :t 165% in the nonchemotherapy group (P> 0.10).
Histology
There was no difference in the average percentage oí ingrowth between the groups at either measurement time (P > 0.10) with values oí 5.5 :t 7.8 and 5.8:t 8.8% at 1 week and 17.1 :t 12.6 and 19.8:t 13.1 % at 2 weeks in the chemotherapy and nonchemotherapy groups, respectively. The increase between 1 and 2 weeks was statistically significant in both groups (chemotherapygroup P < 0.05; nonchemotherapy group P < 0.01).
RNA Analyses
The total RNA content at 1 week was 5.64 :t 2.02 Jl,gfcm in the chemotherapy group and 6.17 :t 4.26 Jl,gfcm in the nonchemotherapy group (P > 0.10). At 2 weeks the corresponding values were 7.53 :t 3.13 and 10.7 :t 5.24 Jl,gfcm, respectively (P > 0.10). The difference in RNA content between 1 and 2 weeks was significant in the nonchemotherapy group (P < 0.01), but not in the chemotherapy group. By 1 week, the mRNA expression mals, but this is, to the best of our knowledge, the first study of this issue in human subjects. A standardized subcutaneous wound was employed since it is unethical to biopsy a newly constructed anastomosis in humans.
The subcutaneous wound and the anastomosis were both exposed to 5-FU in the systemic circulation, but the latter site might algo have been exposed to local 5-FU penetration [14] . As far as the anastomosis is concerned, this model is therefore likely to reflect a "minimum" level of influence. In this study, hydroxyproline was determined as a marker of collagen [15] . In contrast to tissue biopsies, hydroxyproline in the PTFE graft represents only "de novo" collagen and is therefore potentially better suited as a marker of collagen synthesis. Histology and total RNA content might be viewed as indicative of the amount of cells in the graft. Finally, mRNA expression of collagen I shows the cellular signal for collagen formation. The variables in this study thus reflect basic events in wound healing, and a defect in any of them might theoretically lead to serious complications.
The present numerical values of hydroxyproline content were in clase proximity to those observed in a previous study, where the hydroxyproline accumulation after 1 week was 0.45 ILg/cm in control subjects and 0.25 ILg/cm in "debilitated" patients [9] . Trauma [16] , a brief preoperative illness [17] , chronic uremia [18] , and poor .Difference between groups, P = 0.02 (Mann-Whitney U test). ..Difference between 1 and 2 weeks, P < 0.01 (Wilcoxon signed rank test). [19] have been associated with depressed collagen accumulation in humans, whereas protein deficiency negatively influenced collagen deposition in experimental animals [20] .
Hydroxyproline accumulation in the chemotherapy group was reduced to 50% of the control level after 1 week. Because of the larger proportion of women in the chemotherapy group, separate analyses were made according to gender. It was found that the men and the women in the chemotherapy group showed a similar reduction in the hydroxyproline level compared with the corresponding sex in the nonchemotherapy group (data not shown), suggesting that the sex imbalance could not explain the difference. Separate analyses were algo performed with exclusion of patients with surgical complications, with essentially similar results (data not shown). The preoperative registration of other parameters that might affect wound healing (tumor stage, nutritional status, hematological values, extent of surgical trauma) did not reveal any majar differences between the groups. The present findings thus indicate a depressed collagen accumulation during the chemotherapy course. Another observation in this study was the substantial increase in hydroxyproline amount during the second week which took place irrespective of chemotherapy treatment, showing that the negative eff'ect during chemotherapy ceased after the end ofthe course. A similar rige have previously been observed in experimental animals [9, 16] and hydroxyproline levels were also elevated from Day 5 through Day 7 in human subjects [9] . The present study demonstrates that if the time of graft extraction is extended to 2 weeks, there is a continuing steep rige in hydroxyproline deposition.
rrhe mRNA expression of collagen 1 was higher in the chemotherapy group, suggesting that treatment with 5-FU results in a post-transcriptional inhibition of collagen synthesis. l'he mRNA elevation was still present at 2 weeks although the difference was not statistically significant at this time. There was no clear difference in graft weight, histological ingrowth, or total RNA content, suggesting that treatment did not affect cell migration to the same extent as collagen turnover.
This study suggests that collagen accumulation is reduced during a short course ofpostoperative intraperitoneal 5-FU. Since col1.agen is the main determinant of strength in the anastomosis, the present findings indicate that anastomotic complications might result from intraperitoneal 5-FU therapy shortly after surgery, not only in experimental animals, but algo in human subjects. The minimum requirements for uneventful healing is however not known, and there has been no great increase in surgical complications reported after adjuvant intraportal 5-FU infusion [21] [22] [23] [24] [25] . Nevertheless, the present results call for considerable caution when treating patients with cytotoxic drugs shortly after gastrointestinal surgery.
